Welcome : Guest

Vectura Group Plc (UK) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Vectura Group Plc, which is principally involved in Pharmaceuticals Business. Illustrated with 21 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-12102
Price: $1050
Company Type: Public
Pages: 23
Date: November 2016
Market Data Tables: 21

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Vectura Group Plc's Revenues by Category Worldwide (2015-2016) in Percentage for Royalties, Product Licensing, Technology Licensing, Development Services, and Device Sales......3
Table 2: Vectura Group Plc's Sales by Geographical Region Worldwide (2015-2016) in Percentage for United Kingdom, United States of America, and Rest of Europe......4
Table 3: Vectura Group Plc’s Revenues by Category Worldwide (2015) in Percentage for Royalties, Product Licensing, Technology Licensing, Development Services, and Device Sales......5
Table 4: Vectura Group Plc’s Sales by Geographic Region Worldwide (2015) in Percentage for United Kingdom, Rest of Europe, and United States of America......6
Respiratory Drugs......7
Table 5: Respiratory Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue, and Rhinitis......7
Table 6: Respiratory Therapeutic Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue and Rhinitis......8
Table 7: Respiratory Drugs (Asthama, COPD & Allergic Rhinitis) Market Worldwide (2015) in US$ Million......9
Asthma Drugs......10
Table 8: Asthma Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, North America and Rest of the World......10
Table 9: No. of Asthma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Europe, North America, and Rest of World......11
Table 10: Asthma Drugs Market by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Advair Diskus, Combivent, Proair HFA, Singulair, Spiriva HandiHaler, Symbicort, and Others......12
Chronic Obstructive Pulmonary Disease (COPD) Drugs......13
Table 11: Chronic Obstructive Pulmonary Disease (COPD) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, North America and Rest of the World......13
Table 12: Chronic Obstructive Pulmonary Disease (COPD) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Long Acting Muscarinic Antagonists (LAMA), Long Acting Muscarinic Antagonists (LAMA) and Long Acting β2-Agonists (LABA), and Long Acting β2-Agonists (LABA) and Inhaled Corticosteroid (ICS)......14
Table 13: No. of Chronic Obstructive Pulmonary Disease (COPD) Patients Worldwide (2015) - Percentage Market Share Breakdown for Europe, North America, and Rest of World......15
Table 14: Chronic Obstructive Pulmonary Disease (COPD) and Asthma Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Flixotide and Flovent, Seretide and Advair, Spiriva, Symbicort, Xolair, and Others......16
Table 15: Drugs for Treatment of Chronic Obstructive Pulmonary Disease (COPD) Market Worldwide (2015) in US$ Million......17
Cystic Fibrosis (CF)......18
Table 16: Cystic Fibrosis (CF) Patient Population by Region Worldwide (2015) - Percentage Share Breakdown by Value for Australia, Canada, Rest of Europe, United Kingdom and USA......18
Rescue Therapy......19
Table 17: Rescue Therapy for Treatment of Asthma Attacks & COPD Exacerbations Market Worldwide (2015) in US$ Million......19
Respiratory Therapeutics......20
Table 18: Market Shares of Leading Respiratory Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......20
Haemophilia A......21
Table 19: Market Shares of Leading Haemophilia A Treatment Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value Sales for Baxter International Inc. (Advate), Bayer AG (Kogenate), CSL Behring, LLC (Helixate), Pfizer, Inc. (Refacto) and Others......21
Table 20: Vectura Group Plc’s Sales by Geographic Region Worldwide (2014) in Percentage for United Kingdom, Rest of Europe and Others......22
Table 21: Vectura Group Plc’s Revenues by Category Worldwide (2013-2014) in Percentage for Royalties, Product Licensing, Technology Licensing, Development Services and Device Sales......23